These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3742982)

  • 21. Muzolimine therapy in patients with congestive heart failure in comparison with furosemide pretreatment. Effect on digoxin plasma concentration.
    Kahles H; Ertl G; Riegger G; Liebau G; Kochsiek K
    Z Kardiol; 1985; 74 Suppl 2():24-6. PubMed ID: 4002799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Step-dose of muzolimine at different stages of chronic renal failure: comparison with furosemide.
    Morachiello P; Coli U; Landini S; Fracasso A; Righetto F; Scanferla F; Bazzato G
    Z Kardiol; 1985; 74 Suppl 2():115-20. PubMed ID: 4002784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of muzolimine in aortic insufficiency with different levels of left ventricular function.
    Dalla Volta S; Scognamiglio R; Sorbio MD; Fasoli G; Maragno I
    Z Kardiol; 1985; 74 Suppl 2():13-8. PubMed ID: 4002787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diuretic effect and pharmacokinetic data observed at different stages of chronic renal failure with 240 mg of muzolimine.
    Baumelou A; Singlas E; Ritter W; Merdjan H; Martre H; Brouard R; Chickh-Touami C; Patte R
    Z Kardiol; 1985; 74 Suppl 2():88-91. PubMed ID: 4002810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diuretic effect of muzolimine (Bay g 2821) on hepatogenic ascites.
    Heinrich F; Loew D; Dýcka J
    Curr Med Res Opin; 1976-1977; 4(10):706-15. PubMed ID: 800972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose finding study in chronic congestive heart failure patients. Results of a short- and long-term study.
    Esper RJ; Esper RC; Menna J; Baglivo HP; Spiritoso R; Mosca H; Madoery RJ
    Z Kardiol; 1985; 74 Suppl 2():19-23. PubMed ID: 4002798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic effects of long-term therapy with muzolimine and chlorthalidone in hypertension.
    Galletti F; Strazzullo P; Gagliardi R; Cirillo M; Siani A; Iacone R; Mancini M
    Eur J Clin Pharmacol; 1987; 33(5):515-7. PubMed ID: 3428346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The renin-angiotensin-aldosterone system and blood pressure during oxprenolol treatment in hypertensive patients pretreated with diuretics.
    Salvetti A; Pedrinelli R; Simonini N
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):538-42. PubMed ID: 6757151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-over study of muzolimine and hydrochlorothiazide-amiloride in hypertensive patients.
    Ferrara LA; Strazzullo P; Scillitani A; Mancini M; Gagliardi R
    Eur J Clin Pharmacol; 1985; 28(3):241-4. PubMed ID: 4007027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pharmacodynamic and pharmacokinetic studies of muzolimine in patients with hepatogeneous ascites (author's transl)].
    Loew D; Dýcka J; Pfleiderer T; Ritter W
    Z Gastroenterol; 1980 Oct; 18(10):537-42. PubMed ID: 7456563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemodynamic studies with muzolimine in left ventricular failure complicating acute myocardial infarction.
    Verma SP; Taylor SH
    Z Kardiol; 1985; 74 Suppl 2():37-42. PubMed ID: 4002803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Muzolimine: a new high-ceiling diuretic suitable for patients with advanced renal disease.
    Dal Canton A; Russo D; Gallo R; Conte G; Andreucci VE
    Br Med J (Clin Res Ed); 1981 Feb; 282(6264):595-8. PubMed ID: 6781585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of prostenon on the pressor and depressor humoral systems in patients with resistant arterial hypertension].
    Zeĭnalov FM; Vasil'ev IuM; Volos BE
    Ter Arkh; 1990; 62(8):67-70. PubMed ID: 2274874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amlodipine in ambulatory hypertensive patients: humoral and haemodynamic effects.
    Letizia C; De Ciocchis A; Cerci S; Coassin S; Fisher H; Tarsitani P; Scavo D
    Int J Clin Pharmacol Res; 1993; 13(3):151-9. PubMed ID: 8225698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muzolimine vs. furosemide in nephrotic syndrome: further support of different carrier(s) operating for enteral absorption.
    Bazzato G; Coli U; Landini S; Fracasso A; Righetto F; Scanferla F; Forte M; Morachiello P
    Z Kardiol; 1985; 74 Suppl 2():92-5. PubMed ID: 4002811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Uridine-diphosphoglucose in cirrhotic processes].
    Betancor León P
    Rev Esp Enferm Apar Dig; 1973 Feb; 39(4):463-78. PubMed ID: 4695936
    [No Abstract]   [Full Text] [Related]  

  • 37. [Catecholamine and renin-angiotensin system in blood pressure control in patients with liver cirrhosis].
    Bernardi M; Trevisani F; Santini C; Ligabue A; Gasbarrini G
    Boll Soc Ital Biol Sper; 1981 Jun; 57(12):1293-9. PubMed ID: 7028055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New trends in diuretic therapy. 3rd International Edrul Symposium.
    Z Kardiol; 1985; 74 Suppl 2():1-193. PubMed ID: 4002780
    [No Abstract]   [Full Text] [Related]  

  • 39. [Acute effect of nifedipine on arterial pressure and the renin-angiotensin system in healthy subjects and hypertensives].
    Ribstein J; de Treglode D; Mimran A
    Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():29-32. PubMed ID: 3937502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interference on metabolism induced by muzolimine and chlorthalidone in type II hypertensive diabetics.
    Pagano G; Dal Molin V; Bozzo C; Carta Q
    Z Kardiol; 1985; 74 Suppl 2():80-3. PubMed ID: 3890395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.